Navigation Links
CMC Biologics Highlights Technical Acumen at Upcoming Conferences
Date:4/16/2012

COPENHAGEN and SEATTLE, April 16, 2012 /PRNewswire/ -- CMC Biologics is a leading contract manufacturing organization (CMO) known and respected for its technical excellence in process development and cGMP manufacture of the most complex molecules (blood factors, coagulation factors, growth factors), as well as monoclonal antibodies. CMC Biologics' achievements are based on comprehensive analytical and characterization capabilities, expertise in continuous perfusion systems and single-use (disposable) technologies, and always in full compliance with the most current regulatory requirements and expectations.

(Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

"CMC Biologics is continually innovating to advance biopharmaceutical manufacturing to the next level. Our expertise in cGMP process development and manufacturing puts our clients' projects in an optimal position to succeed," said Gustavo Mahler, Chief Operations Officer for the company. "The opportunity to showcase our knowledge at several upcoming symposia helps to drive improvements in bioprocessing and also keeps us current on industry trends and technologies that are critical to our success."

Highlighting its industry leadership position and technical expertise, CMC Biologics will present and exhibit at the following upcoming biopharmaceutical and biomanufacturing conferences.

Parenteral Drug Association (PDA) Annual Meeting 2012, Phoenix, AZ

Presentation Date and Time:  Tuesday, April 17, 2012 at 2:15 p.m.
Title:  Key Elements in Successful Outsourcing
Presenter:  Morten Munk, Vice President Business Development, Technology Specialist

Presentation Date and Time:  Tuesday
'/>"/>

SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
2. Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
3. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
4. Savient Submits Biologics License Application (BLA) for pegloticase
5. DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
6. Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
7. Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
8. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
9. Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences
10. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
11. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... 2014 According to population studies: “North ... now and 2030." If a population explosion like that ... populous state in the country. , To that end, ... Future of North Carolina Forum on December 16th to ... the necessary infrastructure in place? Enough clean water? And ...
(Date:12/13/2014)... Texas , Dec. 12, 2014  Vermillion, Inc. ... announced today the appointments of Veronica G. H. ... to the Company,s Board of Directors, bringing the total ... independent. Jim LaFrance , Chairman, ... am tremendously pleased to announce the appointments of Veronica ...
(Date:12/13/2014)... 12, 2014  Vaccinex Inc., a clinical-stage ... development of therapeutic monoclonal antibodies to treat ... of a manuscript entitled "SEMA4D compromises blood–brain ... neurodegenerative disease" in the January 2015 issue ... publication highlights an important role for antibodies ...
(Date:12/12/2014)... InSphero AG, the world’s leading provider ... today that data presented recently by Genentech (South San ... more predictive model system for assessment of liver toxicity. ... Annual Functional Analysis and Screening Technologies (FAST) Congress ... InSphero’s 3D InSight™ Human Liver Microtissues to ...
Breaking Biology Technology:North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Vaccinex announces publication of preclinical studies with an anti-SEMA4D antibody in animal models of neuroinflammatory and demyelinating disease 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 2Enhanced Sensitivity of InSphero 3D Liver Microtissues Highlighted at Annual Screening Congress 3
... announced today that is has named Scott Canute, a former ... of Directors.   Over the course of his ... Eli Lilly,s global manufacturing operations.  Most recently, he spent more ... Operations for Genzyme, where he led a major turnaround effort. ...
... 12, 2011 - Two pivotal trials ... ulcerative colitis and Crohn,s disease - Shield ... the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals ... announced that the first patients have been treated in ...
... the search for new computing technologies, the University ... prestigious grants for cutting-edge nanoelectronics research that were ... Research Initiative (SRC-NRI) and the National Science Foundation. ... proposals each to the program," says Peter Kilpatrick, ...
Cached Biology Technology:Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors 2Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10 2Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10 3Notre Dame researchers awarded millions to develop radically new computers 2
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced ... the APAC Region 2015-2019"  report to their offering. ... this market is advances in technology. With continuous ... biometric solutions to the latest standard that meets ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... multicolored, tropical bird with bright blue feathers, a dusty orange ... these birds less than 125 lives on one ... they will no longer exist. One University of Missouri researcher ... farmers and residents on the island inhabited by the kingfishers. ...
... MARC (Minority Access to Research Careers) Program has announced ... of America (GSA) 26th Fungal Genetics meeting in Pacific ... are meant to promote the entry of underrepresented minority ... basic science community and to encourage the participation of ...
... Foundation Inc (OSPFI) was awarded the first IOF-Anlene Nutrition ... ceremony that took place at the IOF World Wide ... March 20, 2011. The grant, valued ... Foundation (IOF) and Fonterra Brands, supports educational programmes and ...
Cached Biology News:MU researcher works to save one of the world's most endangered birds 2Philippine Foundation awarded grant for innovative bone health awareness program 2
Request Info...
We offer solid and solution phase peptide synthesis including a whole range of modifications. Please send the details of your peptide synthesis need to info@rpeptide.com...
Maxi 14 Hybridization Oven. 14 bottle (35 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 medium bottles, pack of mesh, bottle gripper and d...
Request Info...
Biology Products: